Safe Supply Streaming Co. Ltd.

SPLY

CA78643W1086

Investment Management & Fund Operators

Delayed Canadian Securities Exchange Other stock markets 14:44:30 22/05/2024 BST			5-day change	1st Jan Change
0.055 ^CAD	0.00%		+22.22%	-71.05%

03-26	Safety Strips Tech Corp announced that it expects to receive CAD 0.75 million in funding from Safe Supply Streaming Co. Ltd.	CI
02-08	Safe Supply Streaming Co. Ltd. Announces Board Changes	CI

Origin Therapeutics Holdings Inc. Announces Resignation of Michael Young as a Director

October 04, 2022 at 05:00 am

Origin Therapeutics Holdings Inc. announced that Michael Young has resigned as a director of the Company in order to focus on his other businesses.

Latest news about Safe Supply Streaming Co. Ltd.

Safety Strips Tech Corp announced that it expects to receive CAD 0.75 million in funding from Safe Supply Streaming Co. Ltd.	03-25	CI
Safe Supply Streaming Co. Ltd. Announces Board Changes	02-08	CI
Safe Supply Streaming Co. Ltd. acquired 7%stake in Safety Strips Tech Corp.	02-07	CI
Safe Supply Streaming Co. Ltd. acquired Origin Therapeutics Holdings Inc. in a reverse merger transaction for CAD 0.35 million.	20/09/23	CI
Safe Supply Streaming Co. Ltd. entered into a binding letter of intent to acquire Origin Therapeutics Holdings Inc. in a reverse merger transaction.	30/01/23	CI
Origin Therapeutics Holdings Inc. Announces Executive Changes	13/01/23	CI
Origin Therapeutics Holdings Inc. Elects Jonathan Goldman as New Director	31/10/22	CI
Origin Therapeutics' Portfolio Firm Clairvoyant Gets Finnish Agency's Approval for Phase 2 Psilocybin Therapy Trial	19/10/22	MT
Origin Therapeutics Holdings Inc. Announces Resignation of Michael Young as a Director	04/10/22	CI
Xpira Pharmaceuticals Receives FDA Approval for Psilocybin Trial IND Application	22/09/22	CI
Origin Therapeutics Holdings Inc. Appoints Michael Galego as New Director	09/09/22	CI

Chart Safe Supply Streaming Co. Ltd.

Duration

Period

More charts

Safe Supply Streaming Co Ltd. is engaged in investing in the legal and regulated supply of drugs. The Companyâs focus is investing and incubating companies across the ecosystem to address the physical, financial, and emotional damage from drug abuse with products, solutions and technologies. Its portfolio includes CannaLabs, and Safe Supply Licensing Co. CannaLabs is licensed by Health Canada, engaged in conducting cutting-edge research on methylenedioxymethamphetamine (MDMA), cocaine, dimethyltryptamine, ketamine and other psychoactive compounds that will be foundational to the development of the safe supply ecosystem. It is also engaged in conducting analytics and testing for compounds manufactured in Canada or imported. Safe Supply Licensing Co is an application process for a dealersâ license pursuant to the Controlled Drugs and Substances Act (CDSA) to be able to import and test controlled substances to connect investee companies to a federal license for Schedule 1 - 3 compounds.

Sector

Investment Management & Fund Operators

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
SAFE SUPPLY STREAMING CO. LTD.	-71.05%	3.12M
BLACKROCK, INC.	-1.30%	120B
UBS GROUP AG	+5.79%	97.54B
BROOKFIELD CORPORATION	+14.30%	69.04B
APOLLO GLOBAL MANAGEMENT, INC.	+21.20%	65.26B
BANK OF NEW YORK MELLON CORPORATION (THE)	+12.90%	44.18B
AMERIPRISE FINANCIAL, INC.	+14.97%	43.11B
3I GROUP PLC	+19.70%	36.3B
T. ROWE PRICE GROUP INC.	+9.87%	26.27B
STATE STREET CORPORATION	-1.16%	23.22B